6 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 6 of 6 clinical reviews.
A clinical review of what is and is not established about Adderall XR pharmacogenomics, cardiovascular risk, and trial representation in Black and African ancestry patients, with a framework for monitoring and specialist referral.
A guide to Adderall XR dosing in East Asian patients, covering CYP2D6 and CYP2C19 polymorphism rates, ethnicity-stratified pharmacokinetic data, and practical dose-titration strategies.
A clinician-focused evidence review of Adderall XR (mixed amphetamine salts) dosing considerations for Hispanic and Latino patients, covering CYP2D6 pharmacogenomics, comorbidity patterns, and practical titration guidance. Drafted by the HealthRX.com medical team for clinician use; pending qualified medical review.
How CYP2D6 variants, metabolic comorbidities, and pharmacogenomic data shape Adderall XR safety considerations for Hispanic and Latino patients.
A clinical deep-dive into pharmacogenomic, metabolic, and trial-representation factors that may alter Adderall XR efficacy in Hispanic and Latino patients with ADHD, including CYP2D6 variants, obesity phenotypes, and dosing considerations.
Evidence-based review of how CYP2D6 polymorphisms, cardiovascular risk thresholds, and trial underrepresentation affect Adderall XR efficacy and safety in South Asian populations.